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Abstract
Background: Most of the clinical trials involving cognitive-behavioral therapy (CBT) for the treatment of anorexia nervosa (AN) used the individual therapy 
format, and few have been dedicated to adapting and assessing the effects of the group format. Objectives: To assess the applicability and effects of a group 
CBT program for Brazilian adolescents with AN. Methods: Open clinical trial with 22 patients with AN divided into an intervention group – IG (n = 11; CBT, 
psychiatry, nutrition and family psychoeducation-6 months) and a control group – CG (n = 11; psychiatry, nutrition and family psychoeducation-6 months). 
Data collected at baseline, at the end of groups and six months after the completion were: weight, height, body mass index and Eating Disorder Examination 
Questionnaire (EDE-Q) used to assess the severity of AN symptoms. Results: Baseline homogeneous groups, with 91% adherence in the IG vs. 54% in the CG 
(p = 0.05). Participants in both groups regained weight and decreased symptoms of eating disorders at the end of groups. Comparing the EDE-Q scores IG 
presented a statistically significant difference in the restraint subscale of the EDE-Q between the end-of-group and the follow-up (p = 0.01). Discussion: Group 
CBT program produced positive effects and was applicable in Brazilian adolescents with AN as an adjuvant to multidisciplinary treatment.
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Introduction
Anorexia nervosa (AN) is a serious eating disorder, which stands out 
among psychiatric disorders because it has the highest mortality rate 
in the general population affected1. With typical onset in adolescence, 
it can affect up to 0.7% of girls at this phase, while being associated 
with family, sociocultural and biological risk factors2. Better 
prognoses are usually found in younger patients when treated early 
in the onset of symptoms2. 
A recent systematic review3 indicated that the most tested model 
of treatment in childhood and adolescence is family-based therapy 
(FBT)4, which is recommended by the international reference 
guidelines in mental health, such as those of the National Institute 
for Health and Clinical Excellence5. However, even this treatment 
modality may not be adequate for all families or patients5 and the 
results are considered to be modest3. The authors of the study consider 
further studies to be needed due to the scarcity of clinical trials, the 
methodological weaknesses and the different designs tested. 
CBT and CBT-E have also been studied as recommended 
alternatives for the treatment of these patients5. One of the basic 
assumptions of CBT is that individuals develop and maintain basic 
beliefs throughout their lives that interfere with and influence how 
they perceive themselves, as well as how they perceive the world 
around them6. In the case of AN patients, weight loss is perceived 
as an achievement, indicating self-discipline, whereas weight gain 
is understood as failure and loss of self-control, which seriously 
interferes with self-esteem7. These dysfunctional beliefs about 
physical shape, weight and eating, function as a risk factor for the 
establishment of eating pathology and also as maintainers of this 
condition8.
Most of the randomized trials involving CBT and CBT-E for 
the treatment of AN used the individual therapy format based 
on the models of Garner et al.8, Garner and Bemis9, as well as the 
transdiagnostic model10,11. Despite it being possible to adapt these 
model to the group therapy format, few studies have been dedicated 
to adapting and assessing the effects of the treatment with this 
configuration. 
In particular, in Brazil, where there is a shortage of specialized 
healthcare services for the treatment of eating disorders (ED) in 
the Public Healthcare System (SUS – Sistema Único de Saúde) and 
a waiting list to receive care12, the group format could increase the 
capacity to absorb the existing demand. No study with this objective 
has been tested in Brazil. The objective of the study is to assess the 
applicability and effects of a group CBT program developed in a 
Brazilian teaching hospital for the treatment of AN.
Methods
Participants
This is an open clinical trial with AN patients under 18 years of age, 
that were diagnosed by way of a physician’s assessment using the 
Development and Well-being Assessment (DAWBA), an instrument 
based on ICD-10 and DSM-IV criteria. Patients that had physical 
complications that required hospitalization, risk of suicide and/or 
psychiatric comorbidities prior to AN were excluded from the study. 
Assessment instruments 
Eating disorders examination questionnaire – EDE-Q13,14
Self-reporting questionnaire with 28 questions that aim to assess 
eating disorder symptoms associated with four subscales: restraint, 
concern with weight, concern with physical shape and concern with 
eating. The response options range from 0 to 6 according to the 
number of days or times in the last four weeks that the patient has 
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experienced any of the eating disorder symptoms. The instrument 
was translated by the coordinators of Protad due to the lack of a 
version validated for use in Brazil. 
Development and Well-Being Assessment – DAWBA
A set of questionnaires and interviews aimed at the diagnosis of 
psychiatric disorders in childhood and adolescence, based on ICD-
10 and DSM-IV criteria15. 
Procedures
The sample was divided into two groups: IG, in which the patients 
received psychiatric, nutritional and family psychoeducational 
treatment and were submitted to group Cognitive-Behavioral 
treatment for 6 months; CG, in which the patients were submitted 
to psychiatric, nutritional, family psychoeducational treatment and 
to a control group for 6 months in which the patients maintained 
a food diary. 
The study was developed in a teaching hospital and conducted in 
a Brazilian healthcare service specialized in the treatment of ED in 
childhood and adolescence. The study-design was approved by the 
Research Ethics Committee, under CAAE No.: 20524513.8.0000.0068. 
The data collected at baseline, at the end and six months after 
the respective completion were: weight, height, body mass index 
(BMI) and the Eating Disorder Examination Questionnaire (EDE-Q) 
used to assess the severity of AN symptoms. The instruments were 
applied by the psychologists who were not directly involved in the 
patients’ treatment. 
CBT Program
The CBT program was developed based on a model used in the 
respective mental health department and the models of Garner 
et al.8, as well as the Fairburn transdiagnostic model11, used in 
randomized studies on CBT and AN, while respecting the adaptation 
for adolescents and for the group format. The initial model lasted 
three months, with 12 to 14 non-manualized sessions, with favorable 
clinical outcomes, despite not yet being tested in clinical trials.  
The current program was structured in 24 manualized sessions held 
in a group setting, lasting 90 minutes, over a six-month period. The 
group was led by psychotherapists specialized in CBT. Hand-crafted 
glasses were developed to symbolize the main cognitive distortions 
present in AN patients, as well as a head band that the adolescents 
were to use when they identified with thoughts associated with AN. 
Data analysis
Descriptive and inferential statistical analyses were performed 
using the Statistical Package for Social Science, version 24. The data 
were processed in the software platform Research Electronic Data 
Capture16 (REDCap). Mean and standard deviation for weight, BMI 
and EDE-Q scores were calculated for the groups at baseline, at the 
end-of-groups and at six months of follow-up. The normality of the 
variables was verified by using the Shapiro-Wilk test. 
For the calculation of the difference in the participants’ adhesion 
in each group, the Z Test was used for the proportional difference in 
independent groups. The Mann-Whitney test (numerical variables) 
and the chi-square test (categorical variables) were used to assess, at 
baseline, possible sociodemographic and clinical differences between 
the IG and CG. Differences in baseline vs. end of group and end vs. 
follow-up, within each group, were assessed by the Wilcoxon test. 
Differences in performance between the groups at the end and in 
follow-up were assessed by using a nonparametric repeated-measures 
analysis of variance with two factors. A probability level of 95% (p ≤ 
0.05) was adopted for the rejection of null hypotheses. 
Being adopted as a complete remission criterion was: zero score 
in the EDE-Q and weight recovery according to the percentile 
expected for gender and age, between 25 and 75 (or return to the 
percentile that the patient presented before the ED, except for the 
cases of prior obesity). Partial remission: patients who recovered 
weight but who still had eating psychopathology indicators, or 
patients weighing below the 25th percentile or reported to be 
underweight before the ED, while demonstrating improvement in 
eating psychopathology indicators. 
Results 
The IG and CG were compared at baseline, in order to assess the 
homogeneity of distribution of the participants. Regarding socio-
demographic data in terms of socioeconomic status, family type and 
ethnicity, there were no statistically significant differences between 
the groups. No statistically significant differences were found in 
the clinical variables investigated. Table 1 shows the results for the 
comparisons between the groups. 
Adherence to treatment 
In the IG, of the initial 11 patients in the group, 10 (91%) remained 
until the end. In the CG, of the initial 11 patients, 6 (54%) patients 
remained until the end, with this difference being considered 
statistically significant (Z = 1.91, p = 0.05). 
Remission at the end of groups 
At the end, 2 (20%) IG patients presented complete remission of 
symptoms vs. 1 (16.7%) of the CG (Z = 0.16, p = 0.86). Partial 
remission occurred in 8 (80%) IG patients vs. 5 (83.3%) in the CG 
(Z = -0.17, p = 0.86). At the end in the IG, 10 (100%) patients were 
between the 25-50 percentiles or higher vs. 6 (100%) in the CG. 
Remission at follow-up 
In the follow-up of the IG, 3 (30%) presented complete remission 
vs. 1 (16.6%) of the CG (Z = 0.59, p = 0.54). At this stage, 7 (70%) 
from the IG presented partial remission vs. 5 (83.3%) from the CG 
(Z = -0.60, p = 0.54). At the follow-up stage, 7 (70%) participants 
were in the 25-50 percentiles vs. 6 (100%) from the CG (Z = -1.48, 
p = 0.13) (Table 2). 
Table 1. Comparison of clinical characteristics of the IG and CG at baseline 
Intervention Group 
(IG) (N = 10)
Control Group (CG)  
(N = 06)
Mann-
Whitney 
Variables Mean SD Mean SD p-value
Years of age 14.80 1.28 14.00 1.69 0.175
Duration of symptoms 
(months) 
12.30 6.39 6.83 1.47 0.127
Initial weight (kg) 46.40 5.2 44.10 7.61 0.828
Initial height (cm) 162.1 5.6 157.8 4.8 0.158
Initial BMI (kg/m²) 17.62 1.51 17.56 2.22 0.745
Weight loss (kg) 9.10 6.47 10.10 3.46 0.581
EDE-q (Global) 3.25 1.83 4.56 0.75 0.159
EDE-q (Restraint) 3.20 1.94 4.60 0.82 0.230
EDE-q (Weight Concern) 3.48 1.95 4.73 1.00 0.210
EDE-q (Shape Concern) 3.76 1.81 5.12 0.81 0.127
EDE-q (Eating Concern) 2.56 1.92 3.80 1.33 0.276
N (%) N (%) P value
Chi-square 
Depression 2 (20%) 2 (33.3%) 0.551
Anxiety 3 (30%) 3 (50%) 0.424
Amenorrhea 7 (70%) 5 (83.33%) 0.792
Source: study data.
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Intragroup analysis 
There was a statistically significant difference in all variables analyzed 
after the IG. Mean weight gain and change in BMI remained the same 
in the follow-up. With the exception of the weight concern subscale, 
all the variables investigated by the EDE-Q improved in the follow-up. 
In the CG, at the end, significant differences in weight, BMI 
and in all variables assessed by EDE-Q were also found, with the 
exception of eating and shape concern subscales. In the follow-up, 
mean weight and BMI in the CG were statistically greater than those 
after the intervention. No significant difference was found in the 
variables of the EDE-Q. 
Intergroup analysis 
At the end of groups there was no statistically significant difference in 
any of the variables investigated. In the follow-up, despite the EDE-Q 
restraint subscale being the only subscale presenting a statistically 
significant difference in the comparison between IG and CG (W = 
6.19, p = 0.012), the analysis of the means of all the EDE-Q scales were 
lower in the IG, which indicates a lower severity of ED symptoms. 
Discussion
The results of this clinical trial demonstrated that the group CBT 
program is applicable, while having tools that were well accepted by 
the adolescents and is possibly responsible for the patients’ improved 
treatment adherence in comparison with the CG. These results are 
in line with a recent systematic review that assessed the efficacy and 
adherence of CBT in 16 studies17. 
In the present study, complete remission was observed in 20% 
of patients at the end of the group therapy and in 30% at follow-up. 
Similar results were found in another study18, which found complete 
remission in 19% at the end of treatment and 33% in the second 
year of follow-up. The clinical trial19 found slightly higher complete 
remission rates: 30% at the end of treatment and 33% at three years 
of follow-up. 
Partial remission was achieved by 80% of patients at the end-
of-group in the IG and by 70% at follow-up. It was not possible to 
compare these results with those of other studies due to lack of data 
or methodological differences. 
In this study, the IG patients presented a mean weight gain and 
improvement in the means for eating symptoms at the end of group 
and at follow-up. This result is in line with previous studies18,20-22 and 
is a preliminary indicator of the positive effects of multidisciplinary 
treatment using CBT. 
The majority of IG patients maintained their respective weight 
gain between the end-of-group and follow-up, except those who 
were discharged immediately following the end-of-group. Despite 
presenting worse results in comparison with those observed in the 
CG in terms of regained weight, the reduction of ED symptoms 
assessed by the EDE-Q was more expressive (in descriptive terms) 
in the IG, while showing a statistical difference in the comparison 
between the groups in the subscale which assesses restraint, in the 
follow-up. A similar result, with regard to the reduction of symptoms, 
was presented in a study23 that compared CBT with Psychodynamic 
Therapy. 
The CG did not present a significant statistical difference in the 
improvement of the eating symptoms between the end-of-group 
and the follow-up; whereby the intervention group continued to 
maintain improvement in three of the four subscales of the EDE-Q: 
restraint, eating concern and shape concern. The only subscale that 
did not present a significant statistical difference between the end-
of-group and the follow-up in the intervention group was related to 
the weight concern.  
As pointed out in a systematic review17, CBT appears to be 
useful in preventing the risk of relapse in the future and the fact that 
IG demonstrated continued improvement in symptoms between 
the end-of-group and follow-up may support this observation, 
for example, the study by Carter et al.24 who observed, in patients 
treated with CBT, the permanence without eating symptoms for a 
longer period of time. 
Despite a weight gain being found in both groups, changes in 
dysfunctional beliefs regarding body, shape and eating were more 
visible in the IG, as assessed through the subscales of the EDE-Q. 
CBT in the treatment of EDs aims to modify the mechanisms that 
maintain the eating psychopathology11. Since dysfunctional beliefs 
are risk factors for engaging the diet and weight loss, which in turn 
are triggers for the reappearance of ED, it is therefore necessary to 
address these issues. This measure is indicative of better long-term 
prognostics24. 
Table 2. Results of assessments performed between the baseline, the end and follow-up for the intervention and control groups
 Variables
Intervention Group (IG) 
(n = 10)
Control Group (CG) 
(n = 06) IG CG IG CG
Interaction
IG vs. CG 
Interaction
IG vs. CG 
Baseline (T0) End (T1) Follow-up (T2) Baseline (T0) End (T1)
Follow-up 
(T2) T0-T1 T1-T2 T0-T1 T1-T2
  M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) P* P* P* P* P** P**
Weight (kg) 46.3 (5.2) 52.2 (5.7) 52.9 (7.5) 44.0 (7.6) 51.5 (9.2) 53.5 (10.8) 0.005 0.028 0.575 0.028 0.403 0.280
BMI (kg) 17.62 (1.51) 19.74 (1.27) 19.95 (2.00) 17.56 (2.22) 20.34 (2.59) 20.96 (3.27) 0.005 0.028 0.508 0.028 0.386 0.112
EDE Q Global 3.25 (1.83) 1.14 (1.53) 0.54 (1.38) 4.56 (0.75) 1.74 (1.57) 1.14 (1.67) 0.007 0.046 0.012 0.345 0.561 0.409
Subscales                    
Restraint 3.20 (1.94) 0.56 (0.94) 0.30 (0.81) 4.60 (0.82) 0.70 (1.04) 0.93 (1.48) 0.007 0.028 0.026 0.414 0.234 0.012
Concern with 
weight
3.48 (1.95) 1.32 (1.94) 0.70 (1.80) 4.73 (1.00) 2.10 (1.64) 1.30 (1.97) 0.014 0.028 0.072 0.344 0.591 0.573
Concern with 
eating
2.56 (1.92) 0.86 (1.20) 0.44 (1.06) 3.8 (1.33) 1.46 (1.46) 0.73 (1.11) 0.018 0.074 0.016 0.131 0.585 0.952
Concern with 
shape 
3.76 (1.81) 1.83 (2.21) 0.75 (1.86) 5.12 (0.81) 2.71 (2.60) 1.62 (2.22) 0.036 0.075 0.018 0.345 0.678 0.248
Intervention Group = (Cognitive Behavioral Therapy + psychiatry, nutrition and family psychoeducation), Control group = (psychiatry, nutrition and family psychoeducation). BMI = body mass index, 
EDE-Q = Eating Disorder Examination Questionnaire.
* Wilcoxon test used to compare the means of each variable between the baseline and the end of the IG and CG and between the end and the follow-up. 
** Wald test for the effect of interaction, to assess the difference in performance between the intervention and control groups between the baseline and the end, and between the end-of-groups 
and the follow-up. 
P ≤ 0.05. 
Source: study data.
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This is the first Brazilian clinical trial with a control group to 
assess the effects of group CBT in the treatment of AN in adolescence. 
Therefore, this is a pioneering study, in that it presents a pilot 
program of group CBT adapted for adolescents with AN, while being 
manualized and capable of being replicated. The proposed objectives 
were achieved, however, some methodological weaknesses limit the 
significance of the findings. Although the number of sessions for each 
group was the same, the period of treatment offered to each patient 
varied between groups. In addition, because the CG did not receive 
psychotherapeutic intervention and because of the impossibility of 
blinding in the study, the professionals may have unintentionally 
offered more attention to these patients. In addition, there was no 
control for psychotropic medication for the symptoms of psychiatric 
comorbidities in the two groups, nor for the possible psychotherapeutic 
interventions that the patients of the CG may have undergone during 
the treatment, which translates into a threat to the internal validity of 
the study. As a threat to external validity, the reduced sample size is 
noted, which makes it difficult to generalize the results. 
It is expected that the present study will stimulate additional 
scientific productions on the theme of ED in childhood and 
adolescence, in Brazil. For future studies we recommend replications 
with larger samples, a clinical trial in the Brazilian population 
with longer follow-up periods to better assess the effects of CBT 
in the treatment of adolescents with AN, and comparison between 
individual and group formats. 
The results suggest that the group CBT program produced 
positive effects and was applicable in Brazilian adolescents with AN 
as an adjuvant to multidisciplinary treatment aimed at improving 
adherence and diminishing the risk of relapse.
Brazilian Clinical Trials Registry (ReBec)
RBR-4dpths.
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